Corbus Pharmaceuticals (CRBP)
NASDAQ:CRBP
Holding CRBP?
Track your performance easily

Corbus Pharmaceuticals (CRBP) Ownership - Who Owns Corbus Pharmaceuticals?

2,312 Followers

Corbus Pharmaceuticals (CRBP) Ownership Overview

31.09%8.11%1.83%14.26%44.71%
31.09% Insiders
1.83% Other Institutional Investors
14.26% ETFs
44.71% Public Companies and Individual Investors
The ownership structure of Corbus Pharmaceuticals (CRBP) stock is a mix of institutional, retail, and individual investors. Approximately 24.20% of the company’s stock is owned by Institutional Investors, 31.09% is owned by Insiders, and 44.71% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 24, 2024
xxxxxxxxxxxxx
$7001956
Mar 11, 2024
xxxxxxxxxxxxx
$23327560
Feb 06, 2024
xxxxxxxxxxxxx
$14250000
Jan 30, 2024
xxxxxxxxxxxxx
$9111941

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$512592
Jun 30, 2024
xxxxxxxxxxxxx
$1998059
Jun 30, 2024
xxxxxxxxxxxxx
$11278969

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,375,000Insider19.50%44,151,250
1,045,800Insider8.59%19,441,422
591,161Institution4.85%10,989,683
494,712Institution4.06%9,196,696
420,632Institution3.45%7,819,549
398,350Institution3.27%7,405,327
249,259Institution2.05%4,633,725
171,266Institution1.41%3,183,835
118,562Insider0.97%2,204,068
108,324Institution0.89%2,013,743

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
494,712Institution4.06%9,196,696
108,324Institution0.89%2,013,743
102,898Institution0.84%1,912,874
78,789Institution0.65%1,464,688
52,638Institution0.43%978,540
50,720Institution0.42%942,885
33,067Institution0.27%614,716
16,075Institution0.13%298,834
13,430Institution0.11%249,664
6,217Institution0.05%115,574

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
382,582Institution3.14%7,184,890
329,220Institution2.70%6,791,809
286,185Institution2.35%5,320,179
169,055Institution1.39%3,487,605
57,499Institution0.47%1,079,831
55,701Institution0.46%1,035,482
47,393Institution0.39%977,718
38,666Institution0.32%718,801
36,021Institution0.30%676,474
24,525Institution0.20%460,580

FAQ

Who Owns Corbus Pharmaceuticals (CRBP)?
According to the latest TipRanks data, approximately 1.83% of the company's stock is held by institutional investors, 31.09% is held by insiders, and 44.71% is held by retail investors.
    What percentage of Corbus Pharmaceuticals (CRBP) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 1.83% of Corbus Pharmaceuticals (CRBP) stock is held by institutional investors.
      What percentage of Corbus Pharmaceuticals (CRBP) stock is held by retail investors?
      According to the latest TipRanks data, approximately 44.71% of Corbus Pharmaceuticals (CRBP) stock is held by retail investors.
        Who owns the most shares of Corbus Pharmaceuticals (CRBP)?
        Cormorant Asset Management, LLC owns the most shares of Corbus Pharmaceuticals (CRBP).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis